{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T20:18:22Z","timestamp":1793823502706,"version":"4.6.1"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T00:00:00Z","timestamp":1743811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T00:00:00Z","timestamp":1743811200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82474317"],"award-info":[{"award-number":["82474317"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LR24H270001"],"award-info":[{"award-number":["LR24H270001"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Traditional Chinese Medicine Science and Technology Project of Zhejiang Province","award":["2020ZQ005"],"award-info":[{"award-number":["2020ZQ005"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-02466-x","type":"journal-article","created":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T06:15:07Z","timestamp":1743833707000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Identification of thyroid cancer biomarkers using WGCNA and machine learning"],"prefix":"10.1186","volume":"30","author":[{"given":"Gaofeng","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyuan","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaming","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Xuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huize","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanqiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinglin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,5]]},"reference":[{"key":"2466_CR1","doi-asserted-by":"publisher","first-page":"812","DOI":"10.3389\/fcell.2020.00812","volume":"8","author":"X Wu","year":"2020","unstructured":"Wu X, et al. MicroRNA: another pharmacological avenue for colorectal cancer? Front Cell Dev Biol. 2020;8:812.","journal-title":"Front Cell Dev Biol"},{"key":"2466_CR2","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.cytogfr.2023.06.005","volume":"73","author":"S Li","year":"2023","unstructured":"Li S, et al. Exosomes: another intercellular lipometabolic communication mediators in digestive system neoplasms? Cytokine Growth Factor Rev. 2023;73:93\u2013100.","journal-title":"Cytokine Growth Factor Rev"},{"key":"2466_CR3","doi-asserted-by":"publisher","first-page":"8281718","DOI":"10.1155\/2021\/8281718","volume":"2021","author":"C Hu","year":"2021","unstructured":"Hu C, et al. Oleanolic acid induces autophagy and apoptosis via the AMPK\u2013mTOR signaling pathway in colon cancer. J Oncol. 2021;2021:8281718.","journal-title":"J Oncol"},{"key":"2466_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2023.106777","volume":"191","author":"X Zhang","year":"2023","unstructured":"Zhang X, et al. Research progress on the interaction between oxidative stress and platelets: another avenue for cancer? Pharmacol Res. 2023;191: 106777.","journal-title":"Pharmacol Res"},{"key":"2466_CR5","unstructured":"Ferlay J et al. Global cancer observatory: cancer today. 2024. https:\/\/gco.iarc.who.int\/today."},{"issue":"3","key":"2466_CR6","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"2466_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2023.100939","volume":"68","author":"Y Liu","year":"2023","unstructured":"Liu Y, et al. Radioiodine therapy in advanced differentiated thyroid cancer: resistance and overcoming strategy. Drug Resist Updat. 2023;68: 100939.","journal-title":"Drug Resist Updat"},{"issue":"10387","key":"2466_CR8","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/S0140-6736(23)00020-X","volume":"401","author":"DW Chen","year":"2023","unstructured":"Chen DW, et al. Thyroid cancer. Lancet. 2023;401(10387):1531\u201344.","journal-title":"Lancet"},{"issue":"9","key":"2466_CR9","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1001\/jamaoto.2022.1743","volume":"148","author":"M Sajisevi","year":"2022","unstructured":"Sajisevi M, et al. Evaluating the rising incidence of thyroid cancer and thyroid nodule detection modes: a multinational, multi-institutional analysis. JAMA Otolaryngol Head Neck Surg. 2022;148(9):811\u20138.","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"3","key":"2466_CR10","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1089\/thy.2018.0570","volume":"29","author":"ST Rahman","year":"2019","unstructured":"Rahman ST, et al. Understanding pathways to the diagnosis of thyroid cancer: are there ways we can reduce over-diagnosis? Thyroid. 2019;29(3):341\u20138.","journal-title":"Thyroid"},{"key":"2466_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.112251","volume":"146","author":"Y Liu","year":"2022","unstructured":"Liu Y, et al. Molecular mechanisms of thyroid cancer: a competing endogenous RNA (ceRNA) point of view. Biomed Pharmacother. 2022;146: 112251.","journal-title":"Biomed Pharmacother"},{"key":"2466_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2023.101013","volume":"72","author":"H Shen","year":"2024","unstructured":"Shen H, et al. Radioiodine-refractory differentiated thyroid cancer: molecular mechanisms and therapeutic strategies for radioiodine resistance. Drug Resist Updat. 2024;72: 101013.","journal-title":"Drug Resist Updat"},{"issue":"20","key":"2466_CR13","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1161\/CIRCULATIONAHA.115.001593","volume":"132","author":"RC Deo","year":"2015","unstructured":"Deo RC. Machine learning in medicine. Circulation. 2015;132(20):1920\u201330.","journal-title":"Circulation"},{"issue":"3","key":"2466_CR14","doi-asserted-by":"publisher","first-page":"773","DOI":"10.4143\/crt.2020.974","volume":"53","author":"J Kang","year":"2021","unstructured":"Kang J, et al. LASSO-based machine learning algorithm for prediction of lymph node metastasis in T1 colorectal cancer. Cancer Res Treat. 2021;53(3):773\u201383.","journal-title":"Cancer Res Treat"},{"key":"2466_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2021.678276","volume":"9","author":"P Dai","year":"2021","unstructured":"Dai P, et al. Retrospective study on the influencing factors and prediction of hospitalization expenses for chronic renal failure in China based on random forest and LASSO regression. Front Public Health. 2021;9: 678276.","journal-title":"Front Public Health"},{"key":"2466_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2025.155849","volume":"268","author":"C Wang","year":"2025","unstructured":"Wang C, et al. Deciphering the value of anoikis-related genes in prognosis, immune microenvironment, and drug sensitivity of laryngeal squamous cell carcinoma. Pathol Res Pract. 2025;268: 155849.","journal-title":"Pathol Res Pract"},{"issue":"9","key":"2466_CR17","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.18394","volume":"28","author":"Y Wang","year":"2024","unstructured":"Wang Y, et al. Prognostic value of CDKN2A in head and neck squamous cell carcinoma via pathomics and machine learning. J Cell Mol Med. 2024;28(9): e18394.","journal-title":"J Cell Mol Med"},{"key":"2466_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.684807","volume":"12","author":"Q Guo","year":"2021","unstructured":"Guo Q, et al. The regulatory network and potential role of LINC00973-miRNA-mRNA ceRNA in the progression of non-small-cell lung cancer. Front Immunol. 2021;12: 684807.","journal-title":"Front Immunol"},{"issue":"4","key":"2466_CR19","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1007\/s10142-023-01222-w","volume":"23","author":"LH Cai","year":"2023","unstructured":"Cai LH, et al. DDB2 and MDM2 genes are promising markers for radiation diagnosis and estimation of radiation dose independent of trauma and burns. Funct Integr Genomics. 2023;23(4):294.","journal-title":"Funct Integr Genomics"},{"key":"2466_CR20","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jad.2021.08.005","volume":"295","author":"S He","year":"2021","unstructured":"He S, et al. Signatures of 4 autophagy-related genes as diagnostic markers of MDD and their correlation with immune infiltration. J Affect Disord. 2021;295:11\u201320.","journal-title":"J Affect Disord"},{"key":"2466_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2020.114285","volume":"189","author":"M Sun","year":"2021","unstructured":"Sun M, et al. A nine-lncRNA signature predicts distant relapse-free survival of HER2-negative breast cancer patients receiving taxane and anthracycline-based neoadjuvant chemotherapy. Biochem Pharmacol. 2021;189: 114285.","journal-title":"Biochem Pharmacol"},{"issue":"6","key":"2466_CR22","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/bjc.2012.302","volume":"107","author":"G Dom","year":"2012","unstructured":"Dom G, et al. A gene expression signature distinguishes normal tissues of sporadic and radiation-induced papillary thyroid carcinomas. Br J Cancer. 2012;107(6):994\u20131000.","journal-title":"Br J Cancer"},{"issue":"41","key":"2466_CR23","doi-asserted-by":"publisher","first-page":"4490","DOI":"10.1038\/onc.2011.626","volume":"31","author":"G Tom\u00e1s","year":"2012","unstructured":"Tom\u00e1s G, et al. A general method to derive robust organ-specific gene expression-based differentiation indices: application to thyroid cancer diagnostic. Oncogene. 2012;31(41):4490\u20138.","journal-title":"Oncogene"},{"key":"2466_CR24","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9:559.","journal-title":"BMC Bioinformatics"},{"issue":"1","key":"2466_CR25","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1186\/1471-2105-15-293","volume":"15","author":"P Bardou","year":"2014","unstructured":"Bardou P, et al. jvenn: an interactive Venn diagram viewer. BMC Bioinform. 2014;15(1):293.","journal-title":"BMC Bioinform"},{"issue":"1","key":"2466_CR26","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1023\/A:1010933404324","volume":"45","author":"L Breiman","year":"2001","unstructured":"Breiman L. Random forests. Mach Learn. 2001;45(1):5\u201332.","journal-title":"Mach Learn"},{"issue":"1","key":"2466_CR27","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/j.2517-6161.1996.tb02080.x","volume":"58","author":"R Tibshirani","year":"1996","unstructured":"Tibshirani R. Regression shrinkage and selection via the lasso. J Roy Stat Soc Ser B (Methodol). 1996;58(1):267\u201388.","journal-title":"J Roy Stat Soc Ser B (Methodol)"},{"key":"2466_CR28","doi-asserted-by":"crossref","unstructured":"Chen, T. and C. Guestrin. XGBoost: a scalable tree boosting system. In: Proceedings of the 22nd ACM SIGKDD International conference on knowledge discovery and data mining. 2016. San Francisco: ACM.","DOI":"10.1145\/2939672.2939785"},{"issue":"5","key":"2466_CR29","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman AM, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12(5):453\u20137.","journal-title":"Nat Methods"},{"issue":"2","key":"2466_CR30","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jncc.2024.05.001","volume":"4","author":"W Cao","year":"2024","unstructured":"Cao W, et al. Comparative study of cancer profiles between 2020 and 2022 using global cancer statistics (GLOBOCAN). J Natl Cancer Cent. 2024;4(2):128\u201334.","journal-title":"J Natl Cancer Cent"},{"issue":"4","key":"2466_CR31","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/S2213-8587(22)00035-3","volume":"10","author":"M Pizzato","year":"2022","unstructured":"Pizzato M, et al. The epidemiological landscape of thyroid cancer worldwide: GLOBOCAN estimates for incidence and mortality rates in 2020. Lancet Diabetes Endocrinol. 2022;10(4):264\u201372.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"2466_CR32","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1097\/CM9.0000000000002108","volume":"135","author":"C Xia","year":"2022","unstructured":"Xia C, et al. Cancer statistics in China and United states, 2022: profiles, trends, and determinants. Chin Med J (Engl). 2022;135(5):584\u201390.","journal-title":"Chin Med J (Engl)"},{"issue":"1","key":"2466_CR33","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jncc.2024.01.006","volume":"4","author":"B Han","year":"2024","unstructured":"Han B, et al. Cancer incidence and mortality in China, 2022. J Natl Cancer Cent. 2024;4(1):47\u201353.","journal-title":"J Natl Cancer Cent"},{"issue":"4","key":"2466_CR34","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/bjs.1800740422","volume":"74","author":"JB Anderson","year":"1987","unstructured":"Anderson JB, Webb AJ. Fine-needle aspiration biopsy and the diagnosis of thyroid cancer. Br J Surg. 1987;74(4):292\u20136.","journal-title":"Br J Surg"},{"issue":"1","key":"2466_CR35","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1089\/thy.2006.16.55","volume":"16","author":"R Redman","year":"2006","unstructured":"Redman R, et al. The impact of assessing specimen adequacy and number of needle passes for fine-needle aspiration biopsy of thyroid nodules. Thyroid. 2006;16(1):55\u201360.","journal-title":"Thyroid"},{"issue":"6","key":"2466_CR36","doi-asserted-by":"publisher","first-page":"986","DOI":"10.4158\/EP10077.OR","volume":"16","author":"A Gursoy","year":"2010","unstructured":"Gursoy A, et al. Fine-needle aspiration biopsy of thyroid nodules: comparison of diagnostic performance of experienced and inexperienced physicians. Endocr Pract. 2010;16(6):986\u201391.","journal-title":"Endocr Pract"},{"issue":"4","key":"2466_CR37","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/dc.10361","volume":"29","author":"Z Baloch","year":"2003","unstructured":"Baloch Z, et al. Role of repeat fine-needle aspiration biopsy (FNAB) in the management of thyroid nodules. Diagn Cytopathol. 2003;29(4):203\u20136.","journal-title":"Diagn Cytopathol"},{"issue":"12","key":"2466_CR38","doi-asserted-by":"publisher","first-page":"2826","DOI":"10.3390\/biomedicines12122826","volume":"12","author":"R Hajjar","year":"2024","unstructured":"Hajjar R, et al. The correlation between biological markers and prognosis in thyroid cancer. Biomedicines. 2024;12(12):2826.","journal-title":"Biomedicines"},{"key":"2466_CR39","doi-asserted-by":"publisher","first-page":"1372553","DOI":"10.3389\/fendo.2024.1372553","volume":"15","author":"M Guo","year":"2024","unstructured":"Guo M, et al. Advances in targeted therapy and biomarker research in thyroid cancer. Front Endocrinol (Lausanne). 2024;15:1372553.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2466_CR40","doi-asserted-by":"publisher","first-page":"1533623","DOI":"10.3389\/fendo.2024.1533623","volume":"15","author":"Y Wu","year":"2024","unstructured":"Wu Y, Zhang Z. Editorial: advances in targeted therapy and biomarker research for endocrine-related cancers. Front Endocrinol. 2024;15:1533623.","journal-title":"Front Endocrinol."},{"issue":"1","key":"2466_CR41","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1002\/dc.23044","volume":"42","author":"Y Jia","year":"2014","unstructured":"Jia Y, et al. Diagnostic value of B-RAF(V600E) in difficult-to-diagnose thyroid nodules using fine-needle aspiration: systematic review and meta-analysis. Diagn Cytopathol. 2014;42(1):94\u2013101.","journal-title":"Diagn Cytopathol"},{"issue":"14","key":"2466_CR42","first-page":"1060","volume":"103","author":"B Zhou","year":"2023","unstructured":"Zhou B, et al. Correlation between BRAF(V600E) mutation and aggressive biological behavior of papillary thyroid carcinoma. Zhonghua Yi Xue Za Zhi. 2023;103(14):1060\u20133.","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"3","key":"2466_CR43","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1089\/thy.2017.0322","volume":"28","author":"CC Lubitz","year":"2018","unstructured":"Lubitz CC, et al. Circulating BRAF(V600E) levels correlate with treatment in patients with thyroid carcinoma. Thyroid. 2018;28(3):328\u201339.","journal-title":"Thyroid"},{"issue":"18","key":"2466_CR44","doi-asserted-by":"publisher","first-page":"5396","DOI":"10.3390\/jcm13185396","volume":"13","author":"E Niedziela","year":"2024","unstructured":"Niedziela E, et al. Detection of the BRAF(V600E) mutation in circulating free nucleic acids as a biomarker of thyroid cancer: a review. J Clin Med. 2024;13(18):5396.","journal-title":"J Clin Med"},{"issue":"5","key":"2466_CR45","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.3390\/cancers13051139","volume":"13","author":"E Macerola","year":"2021","unstructured":"Macerola E, et al. Molecular genetics of follicular-derived thyroid cancer. Cancers (Basel). 2021;13(5):1139.","journal-title":"Cancers (Basel)."},{"key":"2466_CR46","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12916-016-0554-1","volume":"14","author":"M Medici","year":"2016","unstructured":"Medici M, et al. Long- versus short-interval follow-up of cytologically benign thyroid nodules: a prospective cohort study. BMC Med. 2016;14:11.","journal-title":"BMC Med"},{"issue":"6","key":"2466_CR47","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1210\/jc.2006-0791","volume":"91","author":"YE Nikiforov","year":"2006","unstructured":"Nikiforov YE. RET\/PTC rearrangement\u2014a link between Hashimoto\u2019s thyroiditis and thyroid cancer\u2026or not. J Clin Endocrinol Metab. 2006;91(6):2040\u20132.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2466_CR48","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1385\/EP:13:1:03","volume":"13","author":"YE Nikiforov","year":"2002","unstructured":"Nikiforov YE. RET\/PTC rearrangement in thyroid tumors. Endocr Pathol. 2002;13(1):3\u201316.","journal-title":"Endocr Pathol"},{"issue":"7","key":"2466_CR49","first-page":"3211","volume":"86","author":"R Elisei","year":"2001","unstructured":"Elisei R, et al. RET\/PTC rearrangements in thyroid nodules: studies in irradiated and not irradiated, malignant and benign thyroid lesions in children and adults. J Clin Endocrinol Metab. 2001;86(7):3211\u20136.","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2466_CR50","first-page":"4116","volume":"83","author":"SL Sugg","year":"1998","unstructured":"Sugg SL, et al. Distinct multiple RET\/PTC gene rearrangements in multifocal papillary thyroid neoplasia 1. J Clin Endocrinol Metab. 1998;83(11):4116\u201322.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2466_CR51","first-page":"435","volume":"52","author":"X Zhang","year":"2017","unstructured":"Zhang X, et al. RET\/PTC rearrangement affects multifocal formation of papillary thyroid carcinoma. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2017;52(6):435\u20139.","journal-title":"Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi"},{"issue":"8","key":"2466_CR52","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1001","volume":"12","author":"C Montero-Conde","year":"2022","unstructured":"Montero-Conde C, et al. Comprehensive molecular analysis of immortalization hallmarks in thyroid cancer reveals new prognostic markers. Clin Transl Med. 2022;12(8): e1001.","journal-title":"Clin Transl Med"},{"issue":"1","key":"2466_CR53","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/s41421-022-00479-y","volume":"8","author":"X Shi","year":"2022","unstructured":"Shi X, et al. Integrated proteogenomic characterization of medullary thyroid carcinoma. Cell Discov. 2022;8(1):120.","journal-title":"Cell Discov"},{"issue":"5","key":"2466_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/ijmm.2021.5034","volume":"48","author":"G Zhu","year":"2021","unstructured":"Zhu G, et al. CircRNA: a novel potential strategy to treat thyroid cancer (review). Int J Mol Med. 2021;48(5):1.","journal-title":"Int J Mol Med"},{"issue":"1","key":"2466_CR55","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1186\/s13046-018-0936-7","volume":"37","author":"W Bi","year":"2018","unstructured":"Bi W, et al. CircRNA circRNA_102171 promotes papillary thyroid cancer progression through modulating CTNNBIP1-dependent activation of \u03b2-catenin pathway. J Exp Clin Cancer Res. 2018;37(1):275.","journal-title":"J Exp Clin Cancer Res"},{"issue":"2","key":"2466_CR56","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s12022-022-09721-5","volume":"33","author":"U Mohan","year":"2022","unstructured":"Mohan U, et al. Systematic review and meta-analysis to identify the immunocytochemical markers effective in delineating benign from malignant thyroid lesions in FNAC samples. Endocr Pathol. 2022;33(2):243\u201356.","journal-title":"Endocr Pathol"},{"issue":"1","key":"2466_CR57","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s11845-022-02976-1","volume":"192","author":"Z Turan","year":"2023","unstructured":"Turan Z, Erk\u0131l\u0131\u00e7 S. TROP2: a potential marker in diagnosis of thyroid neoplasms. Irish J Med Sci. 2023;192(1):99\u2013103.","journal-title":"Irish J Med Sci"},{"issue":"2","key":"2466_CR58","doi-asserted-by":"publisher","first-page":"601","DOI":"10.3892\/ol.2021.12862","volume":"22","author":"Y Wu","year":"2021","unstructured":"Wu Y, et al. P4HA2 promotes cell proliferation and migration in glioblastoma. Oncol Lett. 2021;22(2):601.","journal-title":"Oncol Lett"},{"key":"2466_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2407-14-1","volume":"14","author":"G Xiong","year":"2014","unstructured":"Xiong G, et al. Prolyl-4-hydroxylase \u03b1 subunit 2 promotes breast cancer progression and metastasis by regulating collagen deposition. BMC Cancer. 2014;14:1.","journal-title":"BMC Cancer"},{"issue":"1","key":"2466_CR60","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1186\/s12967-019-2058-1","volume":"17","author":"S Xu","year":"2019","unstructured":"Xu S, et al. The role of collagen in cancer: from bench to bedside. J Transl Med. 2019;17(1):309.","journal-title":"J Transl Med"},{"key":"2466_CR61","doi-asserted-by":"publisher","DOI":"10.1101\/2020.02.05.935221","author":"J Lin","year":"2020","unstructured":"Lin J, et al. P4HA2 is associated with prognosis, promotes proliferation, invasion, migration and EMT in glioma. bioRxiv. 2020. https:\/\/doi.org\/10.1101\/2020.02.05.935221.","journal-title":"bioRxiv"},{"issue":"4","key":"2466_CR62","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202201244RRRR","volume":"37","author":"S Wang","year":"2023","unstructured":"Wang S, et al. CEBPB upregulates P4HA2 to promote the malignant biological behavior in IDH1 wildtype glioma. Faseb J. 2023;37(4): e22848.","journal-title":"Faseb J"},{"issue":"7","key":"2466_CR63","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1093\/abbs\/gmab065","volume":"53","author":"R Shi","year":"2021","unstructured":"Shi R, et al. Collagen prolyl 4-hydroxylases modify tumor progression. Acta Biochim Biophys Sin (Shanghai). 2021;53(7):805\u201314.","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"issue":"12","key":"2466_CR64","first-page":"6051","volume":"13","author":"M Song","year":"2023","unstructured":"Song M, et al. Increased expression of collagen prolyl hydroxylases in ovarian cancer is associated with cancer growth and metastasis. Am J Cancer Res. 2023;13(12):6051.","journal-title":"Am J Cancer Res"},{"key":"2466_CR65","doi-asserted-by":"publisher","first-page":"1335636","DOI":"10.3389\/fcell.2024.1335636","volume":"12","author":"S-A Lee","year":"2024","unstructured":"Lee S-A, et al. Biophysical interplay between extracellular matrix remodeling and hypoxia signaling in regulating cancer metastasis. Front Cell Dev Biol. 2024;12:1335636.","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"2466_CR66","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","volume":"22","author":"A Glaviano","year":"2023","unstructured":"Glaviano A, et al. PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer. Mol Cancer. 2023;22(1):138.","journal-title":"Mol Cancer"},{"issue":"6","key":"2466_CR67","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/ncb2756","volume":"15","author":"F Calvo","year":"2013","unstructured":"Calvo F, et al. Mechanotransduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer-associated fibroblasts. Nat Cell Biol. 2013;15(6):637\u201346.","journal-title":"Nat Cell Biol"},{"issue":"4","key":"2466_CR68","doi-asserted-by":"publisher","first-page":"e139","DOI":"10.1016\/S1470-2045(23)00676-9","volume":"25","author":"IM Browne","year":"2024","unstructured":"Browne IM, et al. Optimal targeting of PI3K\u2013AKT and mTOR in advanced oestrogen receptor-positive breast cancer. Lancet Oncol. 2024;25(4):e139\u201351.","journal-title":"Lancet Oncol"},{"issue":"12","key":"2466_CR69","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1200\/JCO.24.00248","volume":"42","author":"HJ Burstein","year":"2024","unstructured":"Burstein HJ, et al. Endocrine and targeted therapy for hormone receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer-capivasertib-fulvestrant: ASCO rapid recommendation update. J Clin Oncol. 2024;42(12):1450\u20133.","journal-title":"J Clin Oncol"},{"issue":"5","key":"2466_CR70","first-page":"665","volume":"42","author":"L Shang","year":"2022","unstructured":"Shang L, et al. P4HA2 promotes occurrence and progression of liver cancer by regulating the PI3K\/Akt\/mTOR signaling pathway. Nan Fang Yi Ke Da Xue Xue Bao. 2022;42(5):665\u201372.","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"issue":"6","key":"2466_CR71","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s12032-024-02358-w","volume":"41","author":"Y-L Wu","year":"2024","unstructured":"Wu Y-L, et al. P4HA2 contributes to head and neck squamous cell carcinoma progression and EMT through PI3K\/AKT signaling pathway. Med Oncol. 2024;41(6):163.","journal-title":"Med Oncol"},{"issue":"24","key":"2466_CR72","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1038\/s41388-024-03032-1","volume":"43","author":"E Jin","year":"2024","unstructured":"Jin E, et al. P4HA2 activates mTOR via hydroxylation and targeting P4HA2-mTOR inhibits lung adenocarcinoma cell growth. Oncogene. 2024;43(24):1813\u201323.","journal-title":"Oncogene"},{"issue":"1","key":"2466_CR73","doi-asserted-by":"publisher","first-page":"15023","DOI":"10.1038\/s41598-024-64264-5","volume":"14","author":"Z Chi","year":"2024","unstructured":"Chi Z, et al. P4HA2 promotes proliferation, invasion, and metastasis through regulation of the PI3K\/AKT signaling pathway in oral squamous cell carcinoma. Sci Rep. 2024;14(1):15023.","journal-title":"Sci Rep"},{"issue":"8","key":"2466_CR74","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1038\/s41375-024-02313-8","volume":"38","author":"Q Li","year":"2024","unstructured":"Li Q, et al. P4HA2 hydroxylates SUFU to regulate the paracrine Hedgehog signaling and promote B-cell lymphoma progression. Leukemia. 2024;38(8):1751\u201363.","journal-title":"Leukemia"},{"issue":"12","key":"2466_CR75","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1182\/blood-2017-07-794875","volume":"131","author":"W Jiang","year":"2018","unstructured":"Jiang W, et al. Prolyl 4-hydroxylase 2 promotes B-cell lymphoma progression via hydroxylation of Carabin. Blood. 2018;131(12):1325\u201336.","journal-title":"Blood"},{"key":"2466_CR76","doi-asserted-by":"publisher","first-page":"1406853","DOI":"10.1155\/2021\/1406853","volume":"2021","author":"J Lin","year":"2021","unstructured":"Lin J, et al. P4HA2 promotes epithelial-to-mesenchymal transition and glioma malignancy through the collagen-dependent PI3K\/AKT pathway. J Oncol. 2021;2021:1406853.","journal-title":"J Oncol"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-02466-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-02466-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-02466-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T17:57:55Z","timestamp":1743962275000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-025-02466-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,5]]},"references-count":76,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2466"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-02466-x","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,5]]},"assertion":[{"value":"15 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The patient data used in this study were derived from public datasets, hence no ethics committee approval or participant consent was required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent for publication has been obtained from all authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"244"}}